日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors

KHK2455单药治疗及联合mogamulizumab治疗晚期实体瘤患者的首次人体1期研究

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.35939
Yap, Timothy A; Rixe, Olivier; Baldini, Capucine; Brown-Glaberman, Ursa; Efuni, Sergey; Hong, David S; Massard, Christophe; Muzaffar, Jameel; Varga, Andreea; Yilmaz, Emrullah; Ikawa, Yuta; Shiue, Lisa H; Liu, Yi; Hruska, Matthew W; Zhao, Henry; Tokunaga, Akihiro; Sahebjam, Solmaz
发表日期：2025
文献求助 收藏

Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases

在已患有自身免疫性疾病的患者中，免疫检查点抑制剂联合治疗与单药治疗的安全性和有效性

期刊:Oncoimmunology
影响因子:6.3
doi:10.1080/2162402X.2023.2261264
Reid, Pankti; Sandigursky, Sabina; Song, Juhee; Lopez-Olivo, Maria A; Safa, Houssein; Cytryn, Samuel; Efuni, Elizaveta; Buni, Maryam; Pavlick, Anna; Krogsgaard, Michelle; Abu-Shawer, Osama; Altan, Mehmet; Weber, Jeffrey S; Rahma, Osama E; Suarez-Almazor, Maria E; Diab, Adi; Abdel-Wahab, Noha
自身免疫性疾病
免疫/内分泌
发表日期：2023
文献求助 收藏

A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory Lymphoma

Pelabresib (CPI-0610)（一种 BET 蛋白的小分子抑制剂）在复发或难治性淋巴瘤患者中的 I 期研究

期刊:Cancer Research Communications
影响因子:2
doi:10.1158/2767-9764.CRC-22-0060
Kristie A Blum, Jeffrey G Supko, Michael B Maris, Ian W Flinn, Andre Goy, Anas Younes, Suresh Bobba, Adrian M Senderowicz, Sergey Efuni, Ronda Rippley, Gozde Colak, Patrick Trojer, Jeremy S Abramson
肿瘤
淋巴瘤
发表日期：2022
文献求助 收藏

Risk of Toxicity After Initiating Immune Checkpoint Inhibitor Treatment in Patients With Rheumatoid Arthritis

类风湿性关节炎患者开始免疫检查点抑制剂治疗后的毒性风险

期刊:Jcr-Journal of Clinical Rheumatology
影响因子:1.8
doi:10.1097/RHU.0000000000001314
Efuni, Elizaveta; Cytryn, Samuel; Boland, Patrick; Niewold, Timothy B; Pavlick, Anna; Weber, Jeffrey; Sandigursky, Sabina
Checkpoint
关节炎
毒理研究
免疫/内分泌
发表日期：2021
文献求助 收藏

Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis

KHK4083（一种抗OX40单克隆抗体）治疗中度活动性溃疡性结肠炎的随机、递增剂量II期研究

期刊:Crohns Colitis 360
影响因子:2.6
doi:10.1093/crocol/otaa049
Kierkus, Jaroslaw; Pesegova, Marina; Klopocka, Maria; Brankovic, Marija; Kasai, Noriyuki; Efuni, Sergey; Kong, Jennifer; Nakajima, Yu; Jordan, Christina; Matsui, Takeshi; Feagan, Brian G; Strout, Vincent
单克隆抗体
结肠炎
肠炎
发表日期：2020
文献求助 收藏

Corrigendum to: Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis

更正：KHK4083（一种抗OX40单克隆抗体）治疗中度活动性溃疡性结肠炎的随机、递增剂量II期研究

期刊:Crohns Colitis 360
影响因子:2.6
doi:10.1093/crocol/otaa092
Kierkus, Jaroslaw; Pesegova, Marina; Klopocka, Maria; Brankovic, Marija; Kasai, Noriyuki; Efuni, Sergey; Kong, Jennifer; Nakajima, Yu; Jordan, Christina; Matsui, Takeshi; Feagan, Brian G; Strout, Vincent
单克隆抗体
结肠炎
肠炎
发表日期：2020
文献求助 收藏

Optimism and barriers to colonoscopy in low-income Latinos at average risk for colorectal cancer

低收入拉丁裔人群对结肠镜检查的乐观态度及其面临的障碍（这些人患结直肠癌的风险为平均水平）

期刊:Psycho-Oncology
影响因子:3.5
doi:10.1002/pon.3733
Efuni, Elizaveta; DuHamel, Katherine N; Winkel, Gary; Starr, Tatiana; Jandorf, Lina
肠癌
肿瘤
肿瘤免疫
发表日期：2015
文献求助 收藏

Is obesity associated with colorectal cancer screening for African American and Latino individuals in the context of patient navigation?

在患者导航的背景下，肥胖是否与非裔美国人和拉丁裔人群的结直肠癌筛查相关？

期刊:Cancer Causes & Control
影响因子:2.1
doi:10.1007/s10552-014-0415-1
Philip, Errol J; Shelton, Rachel C; Thompson, Hayley S; Efuni, Elizaveta; Itzkowitz, Steven; Jandorf, Lina
肿瘤
肠癌
肿瘤免疫
代谢
肥胖
发表日期：2014
文献求助 收藏

Colorectal cancer screening brochure for Latinos: focus group evaluation

针对拉丁裔人群的结直肠癌筛查手册：焦点小组评估

期刊:Journal of Cancer Education
影响因子:1.3
doi:10.1007/s13187-013-0506-9
Cooperman, Julia L; Efuni, Elizaveta; Villagra, Cristina; DuHamel, Katherine; Jandorf, Lina
肿瘤
肠癌
肿瘤免疫
发表日期：2013
文献求助 收藏